Holocene Advisors LP Grows Stake in Maximus, Inc. (NYSE:MMS)

Holocene Advisors LP raised its holdings in Maximus, Inc. (NYSE:MMSFree Report) by 6.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,927 shares of the health services provider’s stock after buying an additional 239 shares during the quarter. Holocene Advisors LP’s holdings in Maximus were worth $366,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. V Square Quantitative Management LLC bought a new stake in Maximus in the third quarter valued at $25,000. GAMMA Investing LLC lifted its position in shares of Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after purchasing an additional 238 shares during the period. Blue Trust Inc. boosted its stake in shares of Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 262 shares in the last quarter. Archer Investment Corp increased its position in shares of Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after buying an additional 791 shares during the period. Finally, Ariadne Wealth Management LP bought a new position in Maximus in the second quarter worth about $90,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Price Performance

MMS opened at $72.70 on Friday. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 14.54 and a beta of 0.73. The stock has a fifty day simple moving average of $84.71 and a two-hundred day simple moving average of $87.13. Maximus, Inc. has a 12-month low of $71.75 and a 12-month high of $93.97.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.65%. Maximus’s payout ratio is 24.00%.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.

Check Out Our Latest Stock Report on Maximus

Insider Activity at Maximus

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.40% of the stock is currently owned by corporate insiders.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.